Therapeutic applications of polymeric artificial cells

被引:243
作者
Chang, TMS
机构
[1] McGill Univ, Dept Physiol, Artificial Cells & Organs Res Ctr, Fac Med, Montreal, PQ H3G 1H6, Canada
[2] McGill Univ, Dept Med & Biomed Engn, Artificial Cells & Organs Res Ctr, Fac Med, Montreal, PQ H3G 1H6, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1038/nrd1659
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Polymeric artificial cells have the potential to be used for a wide variety of therapeutic applications, such as the encapsulation of transplanted islet cells to treat diabetic patients. Recent advances in biotechnology, molecular biology, nanotechnology and polymer chemistry are now opening up further exciting possibilities in this field. However, it is also recognized that there are several key obstacles to overcome in bringing such approaches into routine clinical use. This review describes the historical development and principles behind polymeric artificial cells, the present state of the art in their therapeutic application, and the promises and challenges for the future.
引用
收藏
页码:221 / 235
页数:15
相关论文
共 138 条
[91]  
PALMOUR RM, 1989, LANCET, V2, P687
[92]   Drug and gene targeting to the brain with molecular Trojan horses [J].
Pardridge, WM .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (02) :131-139
[93]  
Pearce LB, 1998, TISS ENG, P82
[94]  
Peng A, 2004, ACTA PHARMACOL SIN, V25, P15
[95]  
Phillips WT, 1999, J PHARMACOL EXP THER, V288, P665
[96]   Cross-linked polyhemoglobin-superoxide dismutase-catalase supplies oxygen without causing blood-brain barrier disruption or brain edema in a rat model of transient global brain ischemia-reperfusion [J].
Powanda, DD ;
Chang, TMS .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY, 2002, 30 (01) :23-37
[97]   COMPARISON OF ENZYME-KINETICS AND IMMUNOLOGICAL PROPERTIES OF CATALASE IMMOBILIZED BY MICROENCAPSULATION AND CATALASE IN FREE SOLUTION FOR ENZYME REPLACEMENT [J].
POZNANSKY, MJ ;
CHANG, TMS .
BIOCHIMICA ET BIOPHYSICA ACTA, 1974, 334 (01) :103-115
[98]   Microencapsulated genetically engineered live E-coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats [J].
Prakash, S ;
Chang, TMS .
NATURE MEDICINE, 1996, 2 (08) :883-887
[99]   Encapsulation of brewers yeast in chitosan coated carrageenan microspheres by emulsification/thermal gelation [J].
Raymond, MC ;
Neufeld, RJ ;
Poncelet, D .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY, 2004, 32 (02) :275-291
[100]   Crosslinked hemoglobin-superoxide dismutase-catalase scavenges free radicals in a rat model of intestinal ischemia-reperfusion injury [J].
Razack, S ;
DAgnillo, F ;
Chang, TMS .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1997, 25 (1-2) :181-192